Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Change in Account Payables (2019 - 2026)

Protara Therapeutics' Change in Account Payables history spans 8 years, with the latest figure at $1.1 million for Q1 2026.

  • Quarterly Change in Account Payables rose 172.41% to $1.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Mar 2026, up 28.45% year-over-year, with the annual reading at -$873000.0 for FY2025, 163.22% down from the prior year.
  • Change in Account Payables came in at $1.1 million for Q1 2026, up from -$1.6 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.0 million in Q2 2025 to a low of -$2.2 million in Q2 2023.
  • The 5-year median for Change in Account Payables is $64000.0 (2022), against an average of $180941.2.
  • Year-over-year, Change in Account Payables surged 4242.31% in 2022 and then tumbled 1395.97% in 2023.
  • Protara Therapeutics' Change in Account Payables stood at $1.1 million in 2022, then tumbled by 106.2% to -$70000.0 in 2023, then skyrocketed by 2271.43% to $1.5 million in 2024, then tumbled by 202.76% to -$1.6 million in 2025, then skyrocketed by 169.72% to $1.1 million in 2026.
  • Per Business Quant, the three most recent readings for TARA's Change in Account Payables are $1.1 million (Q1 2026), -$1.6 million (Q4 2025), and -$795000.0 (Q3 2025).